Progressive tissue injury in burns is reduced by rNAPc2

Burns

Volumn 32, Issue 8, 2006, Pages 957-963

  Mahajan, Ajay L ^a   Tenorio, Xavier ^a   Pepper, Michael Sean ^b,c   Baetens, Danielle ^b   Montandon, Denys ^a   Schlaudraff, Kai Uwe ^a   Pittet, Brigitte ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c Netcare Unitas Hospital   (South Africa)

Author keywords

Anticoagulation; Burn wound; rNAPc2; Scar contracture

Indexed keywords

RECOMBINANT NEMATODE ANTICOAGULANT PROTEIN 2; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; BURN; CONTROLLED STUDY; FIBRIN FORMATION; HEMOSTASIS; IMMUNOHISTOCHEMISTRY; INJURY SEVERITY; LASER DOPPLER FLOWMETRY; MALE; MICROTHROMBUS; NONHUMAN; PERFUSION; PHOTOGRAPHY; RAT; SCAR FORMATION; SINGLE DRUG DOSE; TISSUE INJURY; VASCULARIZATION; WOUND HEALING;

ANIMALS; ANTICOAGULANTS; BURNS; CICATRIX; CONTRACTURE; FIBRIN; FLOW CYTOMETRY; HELMINTH PROTEINS; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; REGIONAL BLOOD FLOW;

EID: 33751042247     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2006.02.010     Document Type: Article

References (44)

1. Mensik I., Lamme E.N., and Brychta P. Depth of the graft bed influences split-skin graft contraction. Acta Chir Plast 45 3 (2003) 105-108
2. Jackson D.M. The diagnosis of the depth of burning. Br J Surg 40 164 (1953) 588-596
3. Jackson D.M. Second thoughts on the burn wound. J Trauma 9 10 (1969) 839-862
4. Zawacki B.E. Reversal of capillary stasis and prevention of necrosis in burns. Ann Surg 180 1 (1974) 98-102
5. Arturson G. Pathophysiology of the burn wound and pharmacological treatment. The Rudi Hermans Lecture, 1995. Burns 22 4 (1996) 255-274
6. Birch J., Branemark P.I., Nilsson K., and Lundskog J. Vascular reactions in an experimental burn studied with infrared thermography and microangiography. Scand J Plast Reconstr Surg 2 2 (1968) 97-103
7. Ehrlich H.P., Trelstad R.L., and Fallon J.T. Dermal vascular patterns in response to burn or freeze injury in rats. Exp Mol Pathol 34 3 (1981) 281-289
8. Robb H.J. Dynamics of the microcirculation during a burn. Arch Surg 94 6 (1967) 776-780
9. Noble H.G., Robson M.C., and Krizek T.J. Dermal ischemia in the burn wound. J Surg Res 23 2 (1977) 117-125
10. Brozna J.P. Cellular regulation of tissue factor. Blood Coagul Fibrinolysis 1 4/5 (1990) 415-426
11. McVey J.H. Tissue factor pathway. Baillieres Best Pract Res Clin Haematol 12 3 (1999) 361-372
12. Eurenius E., and Rothenberg J. Platelet aggregation after thermal injury. J Lab Clin Med 83 3 (1974) 355-363
13. Arturson G., and Rammer L. Endogenous inhibition of fibrinolysis in patients with severe burns. Acta Chir Scand 140 3 (1974) 181-184
14. Fang P., Ding R., and Kong L. The changes of fibrinolysis in plasma and wounds in rats inflicted with deep partial thickness burns. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 13 4 (1997) 259-263
15. Alizadeh N., Pittet B., Tenorio X., Pyke C., Baetens D., Montandon D., et al. Active-site inactivated FVIIa decreases thrombosis and necrosis in a random skin flap model of acute Ischemia. J Surg Res 122 2 (2004) 263-273
16. Order S.E., Mason Jr. A.D., Walker H.L., Lindberg R.B., Switzer W.E., and Moncrief J.A. Vascular destructive effects of thermal injury and its relationship to burn wound sepsis. J Trauma 147 (1965) 62-71
17. Ehrlich H.P., McGrane W.L., and Rajaratnam J.B. Ancrod prevents vascular occlusion in thermally injured rats. J Trauma 27 4 (1987) 420-424
18. Cappello M., Vlasuk G.P., Bergum P.W., Huang S., and Hotez P.J. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Proc Natl Acad Sci USA 92 13 (1995) 6152-6156
19. Stassens P., Bergum P.W., Gansemans Y., Jespers L., Laroche Y., Huang S., et al. Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc Natl Acad Sci USA 93 5 (1996) 2149-2154
20. Bergum P.W., Cruikshank A., Maki S.L., Kelly C.R., Ruf W., and Vlasuk G.P. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2. J Biol Chem 276 13 (2001) 10063-10071
21. Buddai S.K., Toulokhonova L., Bergum P.W., Vlasuk G.P., and Krishnaswamy S. Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase. J Biol Chem 277 29 (2002) 26689-26698
22. Vlasuk G.P., Bradbury A., Lopez-Kinninger L., Colon S., Bergum P.W., Maki S., et al. Pharmacokinetics and anticoagulant properties of the factor VIIa-tissue factor inhibitor recombinant Nematode Anticoagulant Protein c2 following subcutaneous administration in man. Dependence on the stoichiometric binding to circulating factor X. Thromb Haemost 90 5 (2003) 803-812
23. Saliba Jr. M.J. Heparin in the treatment of burns: a review. Burns 27 4 (2001) 349-358
24. Hirsh J., Warkentin T.E., Shaughnessy S.G., Anand S.S., Halperin J.L., Raschke R., et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 119 1 Suppl (2001) 64S-94S
25. Vlasuk G.P., and Rote W.E. Inhibition of factor VIIa/tissue factor with nematode anticoagulant protein c2: from unique mechanism to a promising new clinical anticoagulant. Trends Cardiovasc Med 12 8 (2002) 325-331
26. Friederich P.W., Levi M., Bauer K.A., Vlasuk G.P., Rote W.E., Breederveld D., et al. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects. Circulation 103 21 (2001) 2555-2559
27. Bianchi A., Jackson D., Maitz P., and Thanakrishnan G. Treatment of bleeding with recombinant factor VIIa in a patient with extensive burns. Thromb Haemost 91 1 (2004) 203-204
28. Lee A., Agnelli G., Buller H., Ginsberg J., Heit J., Rote W., et al. Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation 104 1 (2001) 74-78
29. Moons A.H., Peters R.J., Bijsterveld N.R., Piek J.J., Prins M.H., Vlasuk G.P., et al. Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty. J Am Coll Cardiol 41 12 (2003) 2147-2153
30. Regas F.C., and Ehrlich H.P. Elucidating the vascular response to burns with a new rat model. J Trauma 32 5 (1992) 557-563
31. Sevitt S., Bull J.P., Cruickshank C.N., Jackson D.M., and Lowbury E.J. Failure of an antihistamine drug to influence the course of experimental human burns. Br Med J 2 4775 (1952) 57-62
32. Boykin J.V., Eriksson E., and Pittman R.N. In vivo microcirculation of a scald burn and the progression of postburn dermal ischemia. Plast Reconstr Surg 66 2 (1980) 191-198
33. Chappell V.L., LaGrone L., and Mileski W.J. Inhibition of leukocyte-mediated tissue destruction by synthetic fibronectin peptide (Trp-9-Tyr). J Burn Care Rehabil 20 6 (1999) 505-510
34. Battal M.N., Hata Y., Matsuka K., Ito O., Matsuda H., Yoshida Y., et al. Reduction of progressive burn injury by a stable prostaglandin I2 analogue, beraprost sodium (Procylin): an experimental study in rats. Burns 22 7 (1996) 531-538
35. Bucky L.P., Vedder N.B., Hong H.Z., Ehrlich H.P., Winn R.K., Harlan J.M., et al. Reduction of burn injury by inhibiting CD18-mediated leukocyte adherence in rabbits. Plast Reconstr Surg 93 7 (1994) 1473-1480
36. Mileski W.J., Burkhart D., Hunt J.L., Kagan R.J., Saffle J.R., Herndon D.N., et al. Clinical effects of inhibiting leukocyte adhesion with monoclonal antibody to intercellular adhesion molecule-1 (enlimomab) in the treatment of partial-thickness burn injury. J Trauma 54 5 (2003) 950-958
37. Aggarwal S.J., Diller K.R., Blake G.K., and Baxter C.R. Burn-induced alterations in vasoactive function of the peripheral cutaneous microcirculation. J Burn Care Rehabil 15 1 (1994) 1-12
38. Basse P., Hovgaard D.J., Lohmann M., and Alsbjorn B.F. Microcirculation flow alterations in burn wounds. Acta Chir Plast 35 1/2 (1993) 86-90
39. Baskaran H., Toner M., Yarmush M.L., and Berthiaume F. Poloxamer-188 improves capillary blood flow and tissue viability in a cutaneous burn wound. J Surg Res 101 1 (2001) 56-61
40. Choi M., and Ehrlich H.P. U75412E, a lazaroid, prevents progressive burn ischemia in a rat burn model. Am J Pathol 142 2 (1993) 519-528
41. Jackson D.M. The William Gissane lecture 1982 the burn wound: its character, closure and complications. Burns Incl Therm Injury 10 1 (1983) 1-8
42. Ehrlich H.P. Anti-inflammatory drugs in the vascular response to burn injury. J Trauma 24 4 (1984) 311-318
43. Kowal-Vern A., Gamelli R.L., Walenga J.M., Hoppensteadt D., Sharp-Pucci M., and Schumacher H.R. The effect of burn wound size on hemostasis: a correlation of the hemostatic changes to the clinical state. J Trauma 33 1 (1992) 50-56 [Discussion 56-7]
44. Del Principe D. Antithrombin III in burned children. Minerva Anestesiol 69 5 (2003) 376-380